The Additional Exclusive License to Laguna Blends, Inc. for the CBD Skincare Line, CannaCeuticals, Opens Up Access to Hundreds of Millions of Consumers in Japan, South Korea, Thailand and Germany
CARLSBAD, CA / ACCESSWIRE / November 1, 2016 / ISO International, LLC ("Isodiol"), the Southern California-based hemp cannabinoid innovator, proudly announces additional territories have been extended to the exclusive licensing agreement with Laguna Blends, Inc. which will open access to more than 325.6 million consumers in Asia and Europe for the cannabidiol CBD skincare products, CannaCeuticals.
On Monday, Laguna Blends Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) announced terms of the acquisition from Isodiol. Laguna Blends now holds the exclusive license to sell branded CannaCeutical products and white labeled skincare products in Japan, Germany, Thailand and South Korea.
Stuart Gray, CEO of Laguna Blends, said, "By acquiring the additional exclusive licenses in Japan, Germany, Thailand and South Korea we can capitalize on the global demand for high quality skincare products." Gray went on to say, "We feel there is nothing like the CannaCeutical product line anywhere in the world today and, in a recent clinical study evaluating the efficacy of its CBD facial serum, test subjects using the product noted a 100% overall improvement to the appearance of skin in just two weeks."
To learn more about CannCeuticals and why the line is so unique to the skincare industry, watch this 19-minute interview with Sherrie Berry, the formulator of CannaCeuticals.
https://www.youtube.com/watch?v=EXlAzDAm6FM
The Global Skincare Market Is Anticipated To Reach $147 Billion In Sales By 2020
Youth and vitality are clearly on the minds of consumers worldwide; the non-cannabis global skincare market is projected to exceed $147 billion USD by 2020 according to a recent market research report. The cannabinoid infused skincare product category represents a new opportunity to further expand both the skincare and cannabis industry.
Based on 2016 world population statistics, CannaCeuticals CBD skincare products are now available to hundreds of millions of consumers in:
- Japan: 126,221,113
- S. Korea: 50,568,105
- Thailand: 68,188,211
- Germany: 80,662,587
Cannaceutical's SpheresTM Technology Revolutionizes the Skincare and Cannabis Industry
Cannaceutical's CBD skincare products are made with Swiss-acquired cannabidiol CBD and Spheres TM Technology, a proprietary micro-encapsulated, time-released delivery system. Spheres TM give little bursts of anti-aging ingredients all day long, which enhances penetration to the skin in a more efficient way allowing for faster, more noticeable results. CannaCeuticals is the first company to develop skincare products using anti-aging cannabidiol CBD in this revolutionary delivery system that delivers visible results in just 7 days as shown in the results of the clinical study.
About CannaCeuticals
CannaCeuticals team of formulators are composed of chemists and product developers that analyze every detail, sourcing ingredients from all ends of the earth to create the most balanced, highly efficacious, anti-aging cannabidiol CBD skincare products in the world.
CannaCeuticals CBD anti-aging skincare products incorporate CBD, a superior antioxidant and a potential anti-inflammatory agent, both of which are significant in anti-aging. CannaCeuticals' Swiss heritage influences a sense of unity in its products, and it combines CBD with other essential anti-aging ingredients to create formulas that pack a powerful punch.
Clinical studies were conducted by BioScreen Testing Services, Inc., a third-party FDA approved lab located in the USA. The test subjects that used the CannaCeuticals facial serum noticed a 100% overall improvement of the skin appearance within a two-week period.
Laguna has signed a distribution agreement with ISO International, LLC, a transaction under which Laguna has acquired the exclusive right to market, promote and distribute seven CBD skin care products of CannaCeuticals of California, USA. For product information, visit https://cbdskincream.com/
About Laguna Blends, Inc.
Laguna Blends Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) is engaged in development, sales, marketing and distribution of hemp based products and solutions. Laguana specializes in identifying emerging trends and opportunities such as Cannabidiol (CBD), one of the most useful compounds found in the hemp plant.
Laguna is currently seeking joint ventures and acquisitions to expand its portfolio in the hemp and cannabinoid markets. To learn more, visit www.LagunaBlendsInc.com, Facebook and YouTube.
About Isodiol:
Isodiol and its team of collaborators are a group of companies that together, grow & harvest hemp on an industrial scale, and then process it to extract the non-psychoactive cannabidiol CBD to the highest available purity for worldwide distribution. By utilizing one of the world's largest hemp farms, Isodiol and its partners are the choice for industrial volumes of high-grade, non-psychoactive CBD.
Pharmaceutical, nutraceutical and cosmetic companies worldwide have gained market share due to our products. To follow Isodiol online, visit the Company's website at http://www.isodiol.com, Facebook, Instagram, and Twitter.
Contact:
Denise Mahaffey
Media@isodiol.com
760.908.6565
FORWARD-LOOKING DISCLAIMER
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and future the Company's business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
LEGAL DISCLOSURE
Isodiol does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). Cannabidiol is a natural element of industrial hemp. Isodiol's products are not intended to cure, treat or mitigate any disease states.
SOURCE: Isodiol
ReleaseID: 448033
